Cargando…
Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study
Severe neurological deficit (SND) is a rare but major complication of pyogenic vertebral osteomyelitis (PVO). We aimed to determine the risk factors and the variables associated with clinical improvement for SND during PVO. This case–control study included patients without PVO-associated SND enrolle...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457841/ https://www.ncbi.nlm.nih.gov/pubmed/28538361 http://dx.doi.org/10.1097/MD.0000000000006387 |
_version_ | 1783241620542455808 |
---|---|
author | Lemaignen, Adrien Ghout, Idir Dinh, Aurélien Gras, Guillaume Fantin, Bruno Zarrouk, Virginie Carlier, Robert Loret, Jean-Edouard Denes, Eric Greder, Alix Lescure, François-Xavier Boutoille, David Tattevin, Pierre Issartel, Bertrand Cottier, Jean-Philippe Bernard, Louis |
author_facet | Lemaignen, Adrien Ghout, Idir Dinh, Aurélien Gras, Guillaume Fantin, Bruno Zarrouk, Virginie Carlier, Robert Loret, Jean-Edouard Denes, Eric Greder, Alix Lescure, François-Xavier Boutoille, David Tattevin, Pierre Issartel, Bertrand Cottier, Jean-Philippe Bernard, Louis |
author_sort | Lemaignen, Adrien |
collection | PubMed |
description | Severe neurological deficit (SND) is a rare but major complication of pyogenic vertebral osteomyelitis (PVO). We aimed to determine the risk factors and the variables associated with clinical improvement for SND during PVO. This case–control study included patients without PVO-associated SND enrolled in a prospective randomized antibiotic duration study, and patients with PVO-associated SND managed in 8 French referral centers. Risk factors for SND were determined by logistic regression. Ninety-seven patients with PVO-associated SND cases, and 297 controls were included. Risk factors for SND were epidural abscess [adjusted odds ratio, aOR 8.9 (3.8–21)], cervical [aOR 8.2 (2.8–24)], and/or thoracic involvement [aOR 14.8 (5.6–39)], Staphylococcus aureus PVO [aOR 2.5 (1.1–5.3)], and C-reactive protein (CRP) >150 mg/L [aOR 4.1 (1.9–9)]. Among the 81 patients with PVO-associated SND who were evaluated at 3 months, 62% had a favorable outcome, defined as a modified Rankin score ≤ 3. No factor was found significantly associated with good outcome, whereas high Charlson index [adjusted Hazard Ratio (aHR) 0.3 (0.1–0.9)], low American Spinal Injury Association (ASIA) impairment scale at diagnosis [aHR 0.4 (0.2–0.9)], and thoracic spinal cord compression [aHR 0.2 (0.08–0.5)] were associated with poor outcome. Duration of antibiotic treatment was not associated with functional outcome. SND is more common in cervical, thoracic, and S. aureus PVO, in the presence of epidural abscess, and when CRP >150 mg/L. Although neurological deterioration occurs in 30% of patients in early follow-up, the functional outcome is quite favorable in most cases after 3 months. The precise impact of optimal surgery and/or corticosteroids therapy must be specified by further studies. |
format | Online Article Text |
id | pubmed-5457841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-54578412017-06-09 Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study Lemaignen, Adrien Ghout, Idir Dinh, Aurélien Gras, Guillaume Fantin, Bruno Zarrouk, Virginie Carlier, Robert Loret, Jean-Edouard Denes, Eric Greder, Alix Lescure, François-Xavier Boutoille, David Tattevin, Pierre Issartel, Bertrand Cottier, Jean-Philippe Bernard, Louis Medicine (Baltimore) 4900 Severe neurological deficit (SND) is a rare but major complication of pyogenic vertebral osteomyelitis (PVO). We aimed to determine the risk factors and the variables associated with clinical improvement for SND during PVO. This case–control study included patients without PVO-associated SND enrolled in a prospective randomized antibiotic duration study, and patients with PVO-associated SND managed in 8 French referral centers. Risk factors for SND were determined by logistic regression. Ninety-seven patients with PVO-associated SND cases, and 297 controls were included. Risk factors for SND were epidural abscess [adjusted odds ratio, aOR 8.9 (3.8–21)], cervical [aOR 8.2 (2.8–24)], and/or thoracic involvement [aOR 14.8 (5.6–39)], Staphylococcus aureus PVO [aOR 2.5 (1.1–5.3)], and C-reactive protein (CRP) >150 mg/L [aOR 4.1 (1.9–9)]. Among the 81 patients with PVO-associated SND who were evaluated at 3 months, 62% had a favorable outcome, defined as a modified Rankin score ≤ 3. No factor was found significantly associated with good outcome, whereas high Charlson index [adjusted Hazard Ratio (aHR) 0.3 (0.1–0.9)], low American Spinal Injury Association (ASIA) impairment scale at diagnosis [aHR 0.4 (0.2–0.9)], and thoracic spinal cord compression [aHR 0.2 (0.08–0.5)] were associated with poor outcome. Duration of antibiotic treatment was not associated with functional outcome. SND is more common in cervical, thoracic, and S. aureus PVO, in the presence of epidural abscess, and when CRP >150 mg/L. Although neurological deterioration occurs in 30% of patients in early follow-up, the functional outcome is quite favorable in most cases after 3 months. The precise impact of optimal surgery and/or corticosteroids therapy must be specified by further studies. Wolters Kluwer Health 2017-05-26 /pmc/articles/PMC5457841/ /pubmed/28538361 http://dx.doi.org/10.1097/MD.0000000000006387 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4900 Lemaignen, Adrien Ghout, Idir Dinh, Aurélien Gras, Guillaume Fantin, Bruno Zarrouk, Virginie Carlier, Robert Loret, Jean-Edouard Denes, Eric Greder, Alix Lescure, François-Xavier Boutoille, David Tattevin, Pierre Issartel, Bertrand Cottier, Jean-Philippe Bernard, Louis Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study |
title | Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study |
title_full | Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study |
title_fullStr | Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study |
title_full_unstemmed | Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study |
title_short | Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study |
title_sort | characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: a case–control study |
topic | 4900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457841/ https://www.ncbi.nlm.nih.gov/pubmed/28538361 http://dx.doi.org/10.1097/MD.0000000000006387 |
work_keys_str_mv | AT lemaignenadrien characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT ghoutidir characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT dinhaurelien characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT grasguillaume characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT fantinbruno characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT zarroukvirginie characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT carlierrobert characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT loretjeanedouard characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT deneseric characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT grederalix characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT lescurefrancoisxavier characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT boutoilledavid characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT tattevinpierre characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT issartelbertrand characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT cottierjeanphilippe characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy AT bernardlouis characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy |